Banque Cantonale Vaudoise’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-12,670
Closed -$803K 1344
2021
Q3
$803K Sell
12,670
-976
-7% -$74.3K 0.03% 449
2021
Q2
$1.25M Sell
13,646
-491
-3% -$39K 0.06% 371
2021
Q1
$963K Sell
14,137
-2,906
-17% -$226K 0.05% 377
2020
Q4
$1.24M Buy
17,043
+2,211
+15% +$128K 0.07% 256
2020
Q3
$563K Buy
14,832
+182
+1% +$6.14K 0.04% 406
2020
Q2
$519K Buy
14,650
+1,408
+11% +$40.1K 0.04% 375
2020
Q1
$289K Sell
13,242
-1,282
-9% -$28.7K 0.02% 524
2019
Q4
$313K Buy
+14,524
New +$333K 0.02% 610

Other funds holding CDNA

Banque Cantonale Vaudoise's CDNA Position: Q4 2021 in Review

Banque Cantonale Vaudoise sold out of CareDx (CDNA) in Q4 2021, closing a stake of 12,670 shares — an estimated $803K sold.

Banque Cantonale Vaudoise first reported a position in CDNA in Q4 2019 and held it in 8 quarters. The position peaked at $1.25M in Q2 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.

  • Banque Cantonale Vaudoise reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 12,670 CareDx shares in Q4 2021, an estimated $803K.
  • Banque Cantonale Vaudoise first reported a position in CareDx in Q4 2019 and held it in 8 quarters.
  • Banque Cantonale Vaudoise's CareDx position peaked at $1.25M in Q2 2021.
  • 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.

Based on Banque Cantonale Vaudoise's 13F filing for Q4 2021, filed 14 Feb 2022.